1. ALLA AKTIER
  2. NYHETER
  3. SENZAGEN

SenzaGen

Nyheter SenzaGen Nyheter alla bolag

Invitation to the presentation of SenzaGen’s January-March 2024 interim report

SenzaGen invites journalists, investors and analysts to a livestream presentation on May 15, 2024, at 9:00 CEST at which President and CEO Peter Nählstedt will present the Q1 report 2024.

The conference call, to be held in Swedish, will begin with a presentation, followed by a Q&A session moderated by Carnegie Investment Banks analyst Klas Palin.

The report will be published on May 15, 2024, at 8:30 CEST.

Time: Wednesday May 15, 9:00–10:00 CEST.
Link to the livestream: https://youtube.com/live/kh3swMMDJPI?feature=share

The presentation can be watched afterwards at SenzaGen’s website: https://senzagen.com/investors/presentations/

Contacts

Peter Nählstedt, President and CEO, SenzaGen AB
Email: peter.nahlstedt@senzagen.com | Mobile: +46 700 23 44 31

Tina Dackemark Lawesson, VP Marketing & Communications
Email: tina.lawesson@senzagen.com | Mobile: +46 708 20 29 44

About us

SenzaGen is a corporate group that aims to be a leader in in vitro science and testing, driving the transition from animal testing to methods better suited to reflect human biology. The Company provides high-performance, non-animal test methods and innovation and consulting services based on state-of-the-art technology. Non-animal methods are more effective, more accurate and less expensive than traditional animal-based methods while also helping to reduce the number of laboratory animals. The Company has a growth strategy centered around continued commercialization of its proprietary GARD® and VitroScreen ORA® test platforms, expansion of its test portfolio and evaluation of acquisition opportunities of profitable and growing companies with complementary offerings. SenzaGen has its headquarters and GLP-certified laboratory in Lund, Sweden and subsidiaries in the US and Italy. For more information, please visit: www.senzagen.com.

SenzaGen is listed on Nasdaq Stockholm First North (ticker: SENZA). FNCA Sweden AB is the company’s Certified Adviser. 

Attachments

Invitation to the presentation of SenzaGen’s January-March 2024 interim report

Datum 2024-05-10, kl 08:30
Källa MFN
Bifogade filer
Invitation to the presentation of SenzaGen’s January-March 2024 interim report
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!